BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8626826)

  • 1. Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study.
    Hsi ED; Zukerberg LR; Yang WI; Arnold A
    J Clin Endocrinol Metab; 1996 May; 81(5):1736-9. PubMed ID: 8626826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
    Tominaga Y; Tsuzuki T; Uchida K; Haba T; Otsuka S; Ichimori T; Yamada K; Numano M; Tanaka Y; Takagi H
    Kidney Int; 1999 Apr; 55(4):1375-83. PubMed ID: 10201002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors.
    Rosenberg CL; Motokura T; Kronenberg HM; Arnold A
    Oncogene; 1993 Feb; 8(2):519-21. PubMed ID: 8426754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
    Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A
    Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of cyclin D1/PRAD1 point mutations in human breast cancers and parathyroid adenomas and identification of a new cyclin D1 gene polymorphism.
    Hosokawa Y; Tu T; Tahara H; Smith AP; Arnold A
    Cancer Lett; 1995 Jul; 93(2):165-70. PubMed ID: 7621424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study.
    Vasef MA; Brynes RK; Sturm M; Bromley C; Robinson RA
    Mod Pathol; 1999 Apr; 12(4):412-6. PubMed ID: 10229506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRAD1/cyclin D1 proto-oncogene: genomic organization, 5' DNA sequence, and sequence of a tumor-specific rearrangement breakpoint.
    Motokura T; Arnold A
    Genes Chromosomes Cancer; 1993 Jun; 7(2):89-95. PubMed ID: 7687458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas.
    Hemmer S; Wasenius VM; Haglund C; Zhu Y; Knuutila S; Franssila K; Joensuu H
    Am J Pathol; 2001 Apr; 158(4):1355-62. PubMed ID: 11290553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathogenesis of primary hyperparathyroidism.
    Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cyclin D1/PRAD1 oncogene in human neoplasia.
    Arnold A
    J Investig Med; 1995 Dec; 43(6):543-9. PubMed ID: 8605613
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequent loss of chromosome arm 1p DNA in parathyroid adenomas.
    Cryns VL; Yi SM; Tahara H; Gaz RD; Arnold A
    Genes Chromosomes Cancer; 1995 May; 13(1):9-17. PubMed ID: 7541648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRAD1 (cyclin D1): a parathyroid neoplasia gene on 11q13.
    Arnold A; Motokura T; Bloom T; Rosenberg C; Bale A; Kronenberg H; Ruderman J; Brown M; Kim HG
    Henry Ford Hosp Med J; 1992; 40(3-4):177-80. PubMed ID: 1483873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I membrane klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism.
    Björklund P; Krajisnik T; Akerström G; Westin G; Larsson TE
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4152-7. PubMed ID: 18682507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel cyclin encoded by a bcl1-linked candidate oncogene.
    Motokura T; Bloom T; Kim HG; Jüppner H; Ruderman JV; Kronenberg HM; Arnold A
    Nature; 1991 Apr; 350(6318):512-5. PubMed ID: 1826542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 abnormalities in human parathyroid carcinoma.
    Cryns VL; Rubio MP; Thor AD; Louis DN; Arnold A
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1320-4. PubMed ID: 8200932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis.
    Stojadinovic A; Hoos A; Nissan A; Dudas ME; Cordon-Cardo C; Shaha AR; Brennan MF; Singh B; Ghossein RA
    Hum Pathol; 2003 Jan; 34(1):54-64. PubMed ID: 12605367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
    Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT
    Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma.
    Cryns VL; Thor A; Xu HJ; Hu SX; Wierman ME; Vickery AL; Benedict WF; Arnold A
    N Engl J Med; 1994 Mar; 330(11):757-61. PubMed ID: 7906387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D and oncogenesis.
    Motokura T; Arnold A
    Curr Opin Genet Dev; 1993 Feb; 3(1):5-10. PubMed ID: 8453274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities in the PRAD1 (CYCLIN D1/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines.
    Kurzrock R; Ku S; Talpaz M
    Cancer; 1995 Jan; 75(2):584-90. PubMed ID: 7812927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.